Local Photodynamic Therapy of Gastrointestinal Tumors by Water-soluble Polymerized Fullerene
水溶性聚合富勒烯局部光动力治疗胃肠道肿瘤
基本信息
- 批准号:10470134
- 负责人:
- 金额:$ 7.49万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Fullerene is known to efficiently generate singlet oxygen when irradiated with light. This will facilitate to induce a photodynamic effect on tumor, if its preferential accumulation in the tumor tissue is attained. To explore this tumor targeting of Fullerene, we chemically modified the water-insoluble fullerene with polyethylene glycol (PEG) not only to make fullerene soluble in water but also to enlarge its molecular size. When injected intravenously to mice carrying a tumor mass in the back subcutis, the large-sized, water-soluble fullerene-PEG conjugate exhibited higher accumulation and more prolonged fullerene retention in the tumor tissue than in the normal tissue. The conjugate was excreted from the body with time without being accumulated in a specific organ. Following intravenous injection of fullerene-PEG conjugates to the tumor-bearing mice coupled with exposure of the tumor site to visible light, the volume increase of the tumor mass was suppressed. Histological examination revealed that conjugate injection plus light irradiation strongly induced tumor necrosis without any damage to the overlaying normal skin. The antitumor effect of the conjugates increased with the increasing irradiation power and the fullerene dose, and the treatment with fullerene in a conjugate (424 g/kg) cured tumor at an irradiation power of 107 J/cmィイD12ィエD1. These findings indicate that the PEG-modified fullerene is a high potential agent for photodynamic tumor therapy.
富勒烯在受光照射时能有效地产生单线态氧。如果其在肿瘤组织中优先积累,将有助于诱导对肿瘤的光动力学效应。为了探索富勒烯的肿瘤靶向性,我们用聚乙二醇(PEG)对不溶于水的富勒烯进行了化学修饰,使其可溶于水,并扩大了其分子大小。将大尺寸水溶性富勒烯-聚乙二醇偶联物静脉注射到背部皮下有肿瘤的小鼠体内,在肿瘤组织中比在正常组织中积累更多,富勒烯滞留时间更长。该缀合物随时间排出体外而不积聚在特定的器官中。在荷瘤小鼠静脉注射富勒烯- peg偶联物,并将肿瘤部位暴露在可见光下,肿瘤体积的增加受到抑制。组织学检查显示,缀合物注射加光照射强烈诱导肿瘤坏死,对覆盖的正常皮肤无损伤。随着辐照功率和富勒烯剂量的增加,偶联物的抗肿瘤作用增强,在辐照功率为107 J/cm的情况下,富勒烯(424 g/kg)的偶联物可治愈肿瘤。这些结果表明,聚乙二醇修饰的富勒烯是一种很有潜力的光动力肿瘤治疗药物。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Yasukawa, H.Kimura, Y.Tabata, et al.: "Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovasucularization"Investigative Ophthalmokogy & Visual Science. 40(1). 2690-2696 (1999)
T.Yasukawa、H.Kimura、Y.Tabata 等人:“使用水溶性聚合物靶向递送抗血管生成剂 TNP-470 治疗脉络膜新生血管”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yasuhiko Tabata and Yoshito Ikada: "Potentiation of drug activity by ultrasound."Ultrasound TECNO. 99 (3). 37-49 (1999)
Yasuhiko Tabata 和 Yoshito Ikada:“通过超声波增强药物活性。”超声波 TECNO。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Tabata, Y. Ikada,Y. murakami: "Tumor accumulation of poly (vinyl alcohol) of different sizes after intravenous injection"J. Controlled Release. 50. 123-133 (1998)
Y.Tabata,Y.Ikada,Y.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Tabata, K. Xi, K. Uno, Y. Ikada: "Chemical conjegation of interferon with pullian and its antiviral activity"STP Pharma Sciences. 9. 101-105 (1999)
Y.Tabata、K. Xi、K. Uno、Y. Ikada:“干扰素与普利安的化学缀合及其抗病毒活性”STP Pharma Sciences。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Tabata, Y.Noda, Y.Matsui, et al: "Targrting of tumor necrosisi factor to tumor by use of dextran and metal coordination"J. Controlled Release. 59. 187-196 (1999)
Y.Tabata,Y.Noda,Y.Matsui,等:“利用葡聚糖和金属配位将肿瘤坏死因子靶向肿瘤”J。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TABATA Yasuhiko其他文献
TABATA Yasuhiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TABATA Yasuhiko', 18)}}的其他基金
Creation of novel regenerative therapy technology by using macrophage recruitment
利用巨噬细胞募集创建新型再生治疗技术
- 批准号:
15K12507 - 财政年份:2015
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of tissue engineering technology to modify biological functions for stem cell regeneration medicine
开发组织工程技术改变干细胞再生医学的生物功能
- 批准号:
25242044 - 财政年份:2013
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Challenge in novel approach of regeneration therapy based on the functional modification of macrophages
基于巨噬细胞功能修饰的再生治疗新方法面临的挑战
- 批准号:
25560194 - 财政年份:2013
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Creation of functional cell aggregates confaining bioabsobable hydrogel microspheres for regenerative therapy and research
创建包含生物可吸收水凝胶微球的功能性细胞聚集体,用于再生治疗和研究
- 批准号:
22650110 - 财政年份:2010
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of Technology to Manipulate the Biological Functions of Stem Cells for Cell Therapy of Next Generation
开发操纵干细胞生物学功能的技术以实现下一代细胞治疗
- 批准号:
20220010 - 财政年份:2008
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Development of functional cell scaffolds and bioreactors for regenerative medicine based on stem cells
基于干细胞的再生医学功能细胞支架和生物反应器的开发
- 批准号:
15100009 - 财政年份:2003
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Therapy of Angiogenic Eye Diseases by Novel Drug Targeting Based on Metal Coordination
基于金属配位的新型药物靶向治疗血管生成性眼病
- 批准号:
12470362 - 财政年份:2000
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biomaterials incorporating releasable growth factor
含有可释放生长因子的生物材料
- 批准号:
06680854 - 财政年份:1994
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Postdoctoral Fellowship: MPS-Ascend: Cyclodextrin-Poly(ethylene glycol)-Based Dynamic Covalent Networks
博士后奖学金:MPS-Ascend:基于环糊精聚乙二醇的动态共价网络
- 批准号:
2316707 - 财政年份:2023
- 资助金额:
$ 7.49万 - 项目类别:
Fellowship Award
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
- 批准号:
10504301 - 财政年份:2022
- 资助金额:
$ 7.49万 - 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
- 批准号:
10697334 - 财政年份:2022
- 资助金额:
$ 7.49万 - 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
- 批准号:
10809875 - 财政年份:2022
- 资助金额:
$ 7.49万 - 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
- 批准号:
10798522 - 财政年份:2022
- 资助金额:
$ 7.49万 - 项目类别:
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
使用刷状结构的聚(乙二醇)-DNA 缀合物靶向致癌 KRAS
- 批准号:
10430047 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
使用刷状结构的聚(乙二醇)-DNA 缀合物靶向致癌 KRAS
- 批准号:
10653706 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
使用刷状结构的聚(乙二醇)-DNA 缀合物靶向致癌 KRAS
- 批准号:
10210369 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
使用刷状结构的聚(乙二醇)-DNA 缀合物靶向致癌 KRAS
- 批准号:
10035113 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Rational design of poly(ethylene glycol) derivatives for reduction of antibody responses against poly(ethylene glycol)
合理设计聚乙二醇衍生物以减少针对聚乙二醇的抗体反应
- 批准号:
17K01393 - 财政年份:2017
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




